At SCIINV, we are pioneering the future of healthcare through cutting-edge artificial intelligence. Our mission is to combat the growing global threat of Antimicrobial Resistance (AMR) with innovative solutions.
AMRx®, our AI-based prediction tool, is designed to revolutionize diagnostics and empower healthcare professionals with data-driven insights for timely diagnosis and successful treatments. Join us in the fight against AMR and explore how AMRx® can make a difference in saving lives.
Startup seed grant
SCIINV Biosciences Pvt Ltd, Hyderabad holds the trademark AMRx in India. The company is developing a machine learning platform for predicting uropathogens and their resistance to prescribe suitable urinary infection therapy, and a generative AI-based antimicrobial resistance drug discovery platform.
The Economic Times Healthtech Solution Award 2024Whale Tank Startup Award 2024Business World Healthcare Excellence Award 2025Top 10 Best Startup Awards by HYSEA 2025
ASPIRE BioNEST, Innominds, and Sri Satya Sai Institute of Higher Learning are affiliated with the team.
co-founder
